Title:
LIPID COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2024/032611
Kind Code:
A1
Abstract:
Provided is a drug delivery system, which in particular relates to a lipid composition. The shown lipid composition comprising a therapeutic agent and/or a prophylactic agent such as RNA can be used for delivering the therapeutic agent and/or the prophylactic agent to mammalian cells or organs, so as to, for example, regulate polypeptide, protein, or gene expression.
Inventors:
HUANG LEI (CN)
SHEN MINGYUN (CN)
LI HANGWEN (CN)
SHEN HAIFA (CN)
SHEN MINGYUN (CN)
LI HANGWEN (CN)
SHEN HAIFA (CN)
Application Number:
PCT/CN2023/111745
Publication Date:
February 15, 2024
Filing Date:
August 08, 2023
Export Citation:
Assignee:
STEMIRNA THERAPEUTICS CO LTD (CN)
International Classes:
A61K9/127; A61K39/00; C07C219/16; C07C229/10
Domestic Patent References:
| WO2022233287A1 | 2022-11-10 | |||
| WO2022233291A1 | 2022-11-10 | |||
| WO2017049245A2 | 2017-03-23 |
Foreign References:
| CN113186203A | 2021-07-30 | |||
| CN112129871A | 2020-12-25 | |||
| CN112390838A | 2021-02-23 | |||
| CN114660188A | 2022-06-24 |
Other References:
WEISSMAN DREW; ALAMEH MOHAMAD-GABRIEL; DE SILVA THUSHAN; COLLINI PAUL; HORNSBY HAILEY; BROWN REBECCA; LABRANCHE CELIA C.; EDWARDS : "D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization", CELL HOST & MICROBE, ELSEVIER, NL, vol. 29, no. 1, 1 December 2020 (2020-12-01), NL , pages 23, XP086446442, ISSN: 1931-3128, DOI: 10.1016/j.chom.2020.11.012
Attorney, Agent or Firm:
HANGZHOU TIANHAO PATENT AGENCY CO., LTD. (CN)
Download PDF:
Previous Patent: ELECTRONIC ATOMIZER
Next Patent: COMMUNICATION METHOD AND SYSTEM, AND COMPUTER-READABLE STORAGE MEDIUM
Next Patent: COMMUNICATION METHOD AND SYSTEM, AND COMPUTER-READABLE STORAGE MEDIUM